DOSSIER · UPDATED 18 NOV 2025

Vevo Therapeutics

Vevo Therapeutics, a biotechnology startup, searches for better treatments for more patients using their Mosaic in vivo drug discovery platform and next-generation AI algorithms.

vevo.ai ↗Claim this profile
Founded
2022
Headcount
8
Open roles
0
Last raised
Series A · $30M
SECTION I · THE BRIEF

Inside Vevo Therapeutics

Brief #74118Updated 18 NOV 2025SAN FRANCISCOSOFTWARE COMPANIESSERIES A
Employbl Dossier

Vevo Therapeutics

Vevo Therapeutics, a biotechnology startup, searches for better treatments for more patients using their Mosaic in vivo drug discovery platform and next-generation AI algorithms.

Founded
2022
Headcount
8
Open roles
0
Last raised
Series A · $30M
Section II — RestrictedMembers only
  • Tech stack (Vevo Therapeutics engineering primaries)
  • Hiring focus this quarter
  • Interview format & rubric
  • Comp bands by level
  • Decision-makers in talent
  • Recent news & moves
Open Vevo Therapeutics briefSign in

7-day free trial · $25/mo · cancel anytime

TAGS

Categorized in

Company Collections

These are collections Vevo Therapeutics is a part of. Click on the collection name to view similar companies.

Vevo Therapeutics' Industries

Vevo Therapeutics' Investors

LOCATIONS

Where they work

Vevo Therapeutics Headquarters Location

San Francisco, CA, 94115

Loading map…
FUNDING

Capital raised

Total Amount Raised: $12,000,000

Vevo Therapeutics' Investors

Vevo Therapeutics Funding Rounds

  • Series A

    $30,000,000

  • Seed

    $12,000,000

  • Seed

    $12,000,000

    Seed Investors

    General Catalyst
    Wing Venture Management
    AIX Ventures
    Mubadala Capital Ventures
    Camford Capital
Funding info provided by Diffbot.
EMPLOYEE REVIEWS

On the ground at Vevo Therapeutics

Vevo Therapeutics Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Vevo Therapeutics.

Recent reviews